Hussman Strategic Advisors buys $15.2 Million stake in Masimo Corporation (MASI)

Masimo Corporation (MASI) : Hussman Strategic Advisors scooped up 200,000 additional shares in Masimo Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 12, 2016. The investment management firm now holds a total of 325,000 shares of Masimo Corporation which is valued at $15.2 Million.Masimo Corporation makes up approximately 1.98% of Hussman Strategic Advisors’s portfolio.

Other Hedge Funds, Including , Ubs Asset Management Americas Inc reduced its stake in MASI by selling 4,010 shares or 12.38% in the most recent quarter. The Hedge Fund company now holds 28,388 shares of MASI which is valued at $1.3 Million. Huntington Asset Advisors added MASI to its portfolio by purchasing 12,250 company shares during the most recent quarter which is valued at $574,158. Masimo Corporation makes up approx 0.38% of Huntington Asset Advisors’s portfolio.Bernzott Capital Advisors reduced its stake in MASI by selling 7,225 shares or 1.24% in the most recent quarter. The Hedge Fund company now holds 576,803 shares of MASI which is valued at $26.6 Million. Masimo Corporation makes up approx 4.99% of Bernzott Capital Advisors’s portfolio. Jensen Investment Management Inc added MASI to its portfolio by purchasing 10,260 company shares during the most recent quarter which is valued at $472,883. Masimo Corporation makes up approx 0.01% of Jensen Investment Management Inc’s portfolio.Clarivest Asset Management boosted its stake in MASI in the latest quarter, The investment management firm added 2,150 additional shares and now holds a total of 53,647 shares of Masimo Corporation which is valued at $2.3 Million. Masimo Corporation makes up approx 0.07% of Clarivest Asset Management’s portfolio.

Masimo Corporation opened for trading at $48.61 and hit $48.84 on the upside on Friday, eventually ending the session at $48.63, with a gain of 0.68% or 0.33 points. The heightened volatility saw the trading volume jump to 4,02,692 shares. Company has a market cap of $2,382,141 M.

On the company’s financial health, Masimo Corporation reported $0.53 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on May 4, 2016. Analyst had a consensus of $0.43. The company had revenue of $171.20 million for the quarter, compared to analysts expectations of $165.28 million. The company’s revenue was up 10.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.41 EPS.

Many Wall Street Analysts have commented on Masimo Corporation. Masimo Corporation was Upgraded by Piper Jaffray to ” Overweight” on May 5, 2016. Company shares were Reiterated by Wedbush on May 5, 2016 to “Outperform”, Firm has raised the Price Target to $ 57 from a previous price target of $51 .

Masimo Corporation is a global medical technology company that develops manufactures and markets non-invasive patient monitoring products. The Company’s core business is measure-through-motion and low-perfusion pulse oximetry monitoring known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include non-invasive optical blood constituent monitoring optical organ oximetry monitoring electrical brain function monitoring acoustic respiration monitoring and optical gas monitoring. In addition the Company offers Root patient monitoring and connectivity platform the Radical-7 bedside and portable patient monitor and the Radius-7 wearable wireless patient monitor. The Company also has the Patient SafetyNet remote patient surveillance monitoring system which allows up to 80 patients to be monitored simultaneously through a central station or remotely by care providers through their pagers or smart phones.

Leave a Reply

Masimo Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Masimo Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.